Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results

By Li Shouwei   Jiang Tao   Li Guilin   Wang Zhongcheng  

Neurological Research, Vol. 30, Iss. 6, 2008-07 ,pp. : 567-570

Maney Publishing

Access to resources Recommend Favorite

MGMT repletion after treatment of glioblastoma cells with temozolomide and O6-benzylguanine implicates NFκB and mutant p53

By Vlachostergios Panagiotis J   Hatzidaki Eleana   Papandreou Christos N  

Neurological Research, Vol. 35, Iss. 8, 2013-10 ,pp. : 879-882

Maney Publishing

Access to resources Recommend Favorite

Immunohistochemical profiles of IDH1, MGMT and P53: Practical significance for prognostication of patients with diffuse gliomas

By  

Neuropathology (Electronic), Vol. 35, Iss. 4, 2015-08 ,pp. : 324-335

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer

By Stewart Angela   Bielajew Catherine   Collins Barbara   Parkinson Matthew   Tomiak Eva  

The Clinical Neuropsychologist (Neuropsychology, Development and Cognition: Sec, Vol. 20, Iss. 1, 2006-02 ,pp. : 76-89

Routledge Ltd

Access to resources Recommend Favorite

What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by ¹⁹²Ir brachytherapy?

By Koot R. W.   Habraken J. B. A.   Hulshof M. C. C. M.   Paans A. M. J.   Bosch D. A.   Pruim J.  

Acta Neurochirurgica, Vol. 150, Iss. 4, 2008-04 ,pp. : 345-349

Springer Publishing Company

Access to resources Recommend Favorite